Skip to main content
American Journal of Alzheimer's Disease and Other Dementias logoLink to American Journal of Alzheimer's Disease and Other Dementias
. 2024 Mar 29;39:15333175241241891. doi: 10.1177/15333175241241891

A Longitudinal Dose-Response Curve Between Leisure-Time Physical Activity and the Prevalence of Diabetes Based on the Different Levels of Cognitive Function Among Older Adults

Jungjoo Lee 1, Junhyoung Kim 2, Hyo Jin Ju 3, Sang Joon An 4,✉, Bomi Woo 2
PMCID: PMC11072067  PMID: 38549562

Abstract

This study investigated a dose-response relationship between Leisure-Time Physical Activity participation (LTPA) and the risk of diabetes and a comparison of the risk across different cognitive function groups among older adults. The Health and Retirement Study data were used from 2012 to 2020 (n = 18 746). This study conducted a Cox Proportional Hazard Regression to investigate the Dose-Response Curve between the prevalence of diabetes and the covariates following a level of LTPA participation. The result presented that the Odds Ratio continuously decreased as the level of LTPA participation increased. Among the three cognitive function groups, the high group (OR = .43, P < .05) and the mid group (OR = .71, P < .05) had a larger negative slope coefficient than the low group. This study found that LTPA participation reduces the risk of diabetes and gives evidence for the importance of cognitive function in reducing the prevalence of diabetes.

Keywords: cognitive function, diabetes, physical activity, older adults, dose-response curve

Introduction

Diabetes has emerged as a prominent chronic condition affecting older adults that results in significant health complications including heart disease, nerve damage, and risk for dementia and significant expenses related to medical treatment.1,2 The American Diabetes Association (ADA) has reported that over 26% of older adults suffer from diabetes mellitus and that 1.4 million Americans are diagnosed with diabetes every year.3–7 Older adults who are diagnosed with diabetes typically experience a reduction in their life expectancy of approximately 5 years, which highlights the severity of the impact of this chronic disease on mortality rates in this vulnerable population.8–11

Diabetes in older adults has been associated with a heightened risk of several complications and comorbidities including cardiovascular disease, renal disorders, infections, cancers, and an increased mortality rate.12–15 Thus, based on the statistical data and the observed health challenges and concerns associated with diabetes, researchers have stressed the importance of investigating the prevalence and mortality rates of diabetes and its impact on older adults.16–19 This finding of this investigation will provide researchers with critically needed data that can be used to design effective preventive strategies that can mitigate the growing burden of this disease.

Recently, a growing body of literature has reported findings related to the epidemiological association between diabetes mellitus and cognitive decline that provided conclusive evidence that diabetes is significantly associated with cognitive decline.16–19 One extensively supported mechanism involves the escalation of insulin resistance that leads to persistent elevation of blood glucose levels and the risk of diabetes. 20 Insulin resistance impacts both cerebrovascular and noncerebrovascular pathways and contributes to cognitive impairment in individuals with diabetes. 21 Insulin resistance triggers chronic hyperinsulinemia in the brain that results in elevated levels of beta-amyloid peptide-42, the primary constituent of amyloid plaques.22,23 The presence of amyloid plaques is a defining feature of Alzheimer’s disease, Alzheimer’s Disease and Related Dementias (AD/ADRD), and amnestic cognitive impairment.24,25 Moran et al 26 reported extensive changes in brain metabolites and structures in patients with diabetes that firmly established the association between diabetes and cognitive impairment.

While several studies have demonstrated that worsening memory and attention-processing function is related to the increasing prevalence of diabetes in older adults, the pathogenetic link between declining cognitive function and the risk of diabetes has not yet been fully elucidated.17,27 It is important for researchers to identify the changes in the risk of diabetes being followed by cognitive decline and design and implement interventions that effectively prevent the onset of diabetes among older adults.

It is well established that Leisure-Time Physical Activity (LTPA) is one of the most effective chronic disease prevention strategies for diabetes and the most important factor in promoting the health and wellbeing of older adults with diabetes.28,29 Previous findings presented evidence that LTPA contributes to increased cardiorespiratory fitness, enhanced vigor, improved glycemic control, reduced insulin resistance, optimized lipid profile, blood pressure reduction, and the sustainability of weight loss.30–32 Clinical studies have reported positive effects of LTPA on glycated h Hemoglobin A1C (HbA1C),33,34 triglycerides (TG), and cholesterol levels in individuals with diabetes compared to non-exercise comparison groups. 35 In addition, research has provided evidence that LTPA such as aerobic and exercise activities is associated with a 26% reduction in the prevalence of diabetes 36 and a 33% reduction in HbA1C levels, which are leading indicators of diabetes in older adults. For example, cohort studies have demonstrated an association between regular physical activity, moderate to high cardiorespiratory fitness, and reduced risk of diabetes and mortality in both type 1 and type 2 diabetes populations.37–39 Some studies have investigated the relationship between the level of LTPA participation and the risk of diabetes and found that older adults who frequently participated in LTPA were more likely to reduce the risk of diabetes onset.34,38,39 For example, engaging in a minimum of 150 minutes per week of aerobic physical activity, such as walking or jogging, and incorporating resistance exercises like weight training has been proven to be effective in reducing HbA1C levels and lowering the risk of diabetes. Moreover, moderate to vigorous levels of LTPA have a more significant impact on decreasing HbA1C and the risk of diabetes than lower-intensity LTPA.33,34

While a substantial number of clinical studies have reported that LTPA participation provides benefits that reduce the risk of diabetes and related diabetic symptoms,37–40 there is currently no longitudinal evidence of the relationship between different levels of LTPA participation and the prevalence of diabetes in older adults. Though prior studies investigated how diabetes is associated with cognitive function and have provided evidence that individuals with diabetes are likely to experience cognitive decline,16–19 little research has been conducted to examine the reverse relationship between different levels of cognitive function and the prevalence of diabetes.

In summary, the aim of this study is to: (a) investigate the longitudinal dose-response relationship between LTPA participation and the risk of diabetes, and (b) compare the risk of diabetes in three different cognitive function groups (i.e., low, mid, and high). The hypotheses that guided this investigation included:

Hypothesis 1

Higher levels of LTPA participation reduces the risk of diabetes.

Hypothesis 2

Higher levels of cognitive function reduces the risk of diabetes.

Methods

Data

This study used the Health and Retirement Study (HRS) data from 2012 to 2020 that has been biannually released since 1992 by the University of Michigan. The data includes a wide range of information about the health status of older adults and the demographic characteristics, pension, housing, and job history of individuals over 45 years old. The HRS uses not only a paper-based survey but also interviews (e.g., telephone, in-person) to gain proxy-measured and biofeedback data. While a similar survey format has been used since initial data collection, the HRS has modified the instruments, questionnaires, and domains they have used over time. We employed data from 2012 to 2020 as each dataset in that timeframe is comprised of identical domains and instruments.

The HRS has used their own data collection protocol to follow up with study respondents. The respondents in the survey participant pool have been identified with Person Identification Numbers (PN) and a Household Number (HH). Changes in family structure such as births, deaths, or divorces are recorded in the HH. For instance, if PN1 and PN2 in HH-1 experience a divorce, they are redesignated as PN1 in HH-1 and PN2 in HH-2. Similarly, if an PN1 in HH-1 has a second marriage, the HH-1 has PN1, PN2.

Study Sample

This study tracked participant samples from 2012 to 2020. Figure 1 shows the overview of the longitudinal follow-up of the study sample populations. The study samples were extracted using the following protocol: (a) the year 2012 as the baseline, (b) track from 2012 to 2020, (c) participants must be over 50 years old, and (d) exclude respondents who had null values in a dependent variable during the period. The total study sample of this study following this protocol was 18 746.

Figure 1.

Figure 1.

Flow Chart of the Longitudinal Follow-up of Study Participants.

Measurements

Dependent Variables

Diabetes

The onset of diabetes was screened by a questionnaire item: “Has a doctor told you that you have diabetes?” to which respondents answered either “Yes” or “No.” Each answer was coded as 1 = ‘Yes’ and 0 = ‘No’. The HRS provides information about the time of diabetes onset using an item: “In what year was your diabetes first diagnosed?”

This study encompassed samples that consistently provided the same answers on the diabetes diagnosis questionnaire between 2012 and 2020. For instance, if a study participant indicated that they were diagnosed with diabetes in 2014, they were required to report having diabetes in 2016, 2018, and 2020 to be included in the study sample. We only included respondents who were diagnosed with diabetes after 2012 and used the 2020 data to investigate whether the study participants had diabetes. However, this study did not consider the timing of when participants were diagnosed with diabetes between 2012 and 2020, nor did it include information about whether the diabetes diagnosis was type 1 or type 2.

Independent Variable

Leisure-Time Physical Activity

The Psychosocial domain (i.e., LB) was comprised of information about 21 types of leisure activities. This study extracted two items to construct the LTPA variable: “Play sports or exercise” and “Walk 20 minutes or more”.41,42 A seven point Likert scale was used to assess the level of LTPA participation (1 = ‘Daily’ and 7 = ‘Never relevant’). The scale was reverse coded to use a high score to represent a high level of LTPA participation. We summed LTPA participation each year from 2012 to 2020 to calculate total participation.

Covariates

Cognitive Function The HRS cognition section elicits comprehensive information regarding the cognitive function of older adults via in-person and/or telephone interviews. The HRS has consistently used the telephone Interview for Cognitive Status-27 (TICS-27) for cognitive assessment and collects two types of cognition data using the same instrument: Patient-Reported Outcome (PRO) and Proxy-Measured Outcome (PMO). The HRS interviewer decides whether to use PRO or PMO method based on the responsiveness of the interviewee. If the interviewee can respond reliably to the questionnaire, the interviewer collected data from the interviewee using the PRO method. However, if the interviewee was not reliable and responsive to the questions, the interviewer would use the PMO method that requires support from caregivers. Therefore, PRO data indicates that the respondents are able to answer to the questions independently, and data users can expect PRO data to be reliable. This study employed the PRO method to collect cognitive function data with respondents who were able to engage in the tests without support. These respondents were not considered cognitively impaired, even if they had a low score on each test or had been diagnosed with dementia.

The TICS-27 is comprised of cognitive tests assessing three domains of cognitive function: memory, working memory, and attention and processing speed. The total cognitive function score was derived by adding the results of the three cognitive function tests, with a scoring range of 0 to 27.43–45 The memory domain was assessed using both recall and delayed recall tests. The interviewer presented 10 random words to the interviewees and asked them to recall as many words as possible immediately in the recall test and then asked them to recall the same 10 words again five minutes later in the delayed recall test (e.g., car, tree, cloud). Each correctly answered word had a one-point value and the total memory score ranged from 0 to 20. The seven-subtraction test was used to measure working memory that requires processing and storing information simultaneously. The respondents were asked to subtract 7 from 100 five times (e.g., 100-7 = 93, 93-7 = 86, 86-7 = 79). Each correct answer was given one point resulting in a total score that ranged from 0 to 5. Attention and processing speed were measured using a counting backward test.44,45 The respondents were asked to count backward 10 continuous numbers from 20 in two trials (e.g., 20, 19, 18, 17). Each correct trial has one point value and score ranged from 0 to 2.

A TICS-27 score of 6 or below indicates cognitive impairment, whereas a score falling between 7 and 11 suggests cognitive impairment without meeting the dementia threshold, commonly referred to as MCI. Scores ranging from 12 to 27 are deemed to be within the normal cognitive status range as established by previous studies. Therefore, we classified study samples into three cognitive groups (i.e., low, mid, and high) according to their TICS-27 scores. The low group included scores from 0 to 6, the mid group from 7 to 11, and the high group from 12 to 27. The high group was comprised of participants with higher cognitive function than the mid and low groups.

Age and Sex

Effective coefficient estimation with covariates requires predictable outcomes and low correlation with the study variables to avoid multicollinearity risks. 46 Previous diabetes studies considered covariates such as age, sex, weight, and height.47–49 Thus, we confirmed a correlation with study variables and put age and sex in 2012 as covariates as they were available in the HRS data.

Analysis

This study employed a Cox Proportional Hazard Regression to investigate the Dose-Response Curve (DRC) between the prevalence of diabetes and the covariates (i.e., age, sex, cognitive function) based on varying levels of LTPA participation. The Odds Ratio (OR) indicates the probability that the study sample is diagnosed with diabetes. An OR of 1.0 means that the individual has a 100% risk of diabetes and an OR of .70 indicates that, after a specific intervention, the intervention has reduced the risk of diabetes by 30%, indicating a 70% risk of diabetes. The DRC presents the OR as changing coefficients of covariates. The aim of this study was to calculate each covariate coefficient and describe the OR changes as LTPA participation increases. This study not only visualized the changes of the OR as LTPA levels increased, but also compared the OR in three different levels of cognitive function (i.e., low, mid, and high). All statistical analyses were conducted using the SPSS version 29.0 statistical package. The regression equation was as follows:

Odds Ratio Probability=onset of diabetes1−onset of diabetes=Constant+Age+Sex+Leisure Time Physical Activity OR (low cognitive group)=β0+Age β1+Sex β2+LTPA β3 OR (mid cognitive group)=β0+Age β1+Sex β2+LTPA β4 OR (high cognitive group)=β0+Age β1+Sex β2+LTPA β5

Results

Study respondent demographic data are described in Table 1. The age of respondents ranged from 50 to 109 years old (M = 76.55, SD = 11.82). The sample consisted of 58.3% of females (n = 10 935) and 41.7% males (n = 7811). Almost half of the respondents indicated their marital status as married (54.6%, n = 10 237), while the remainder reported that they were either widowed (22.3%, n = 4175), or divorced (14.8%, n = 2790).

Table 1.

Demographic variables.

Characteristics n %
Age
 50 to 109 years old (mean = 76.55, SD = 11.82) 18 746 100
Gender
 Male 7811 41.7
 Female 10 935 58.3
Marital status
 Married 10 237 54.6
 Living with a partner 13 .00
 Separated 778 4.1
 Divorced 2790 14.8
 Widowed 4175 22.3
 Never married 753 4.02

Total n = 18 746.

Table 2 summarizes the study variables, among which 6.10% (n = 1143) of respondents were diagnosed with diabetes between 2012 and 2020. The independent variables were comprised of information from 2012 to 2020. The total amount of LTPA had a mean of 10.52 mean and an SD of 9.93. The total cognitive function score (M = 47.12, SD = 40.17) was categorized into three groups: the high group (27.0%, n = 4995), the mid group (31.9%, n = 5898), and the low group (42.5%, n = 7853).

Table 2.

Descriptive Statistics.

Variables n Mean SD
Dependent variables .06 .24
 Diabetes 1143 (6.10%)
 Non-diabetes 17 603 (93.90%)
Independent variables (from 2012 to 2020)
 Leisure time physical activity 10.52 9.93
 Cognitive function 47.12 40.17
  High group 4995 (27.0%)
  Mid group 5898 (31.9%)
  Low group 7853 (42.5%)

Total n = 18 746.

The omnibus of the model coefficient was tested (Table 3). This test investigates the likelihood ratio of the chi-square statistic vs the null model. A less than a .05 P value indicates that the current model outperforms the null model. 50 The test revealed a 11 821.82 log-likelihood value (Chi-square = 79.32, df = 4, P < .05).

Table 3.

Omnibus Tests of Model Coefficients.

Overall (score) Change from Previous Step Change from Previous Block
−2 log likelihood Chi-square df Sig Chi-square df Sig Chi-square df Sig
11 821.82 79.32 4 .00 79.82 4 .0 79.82 4 .00

The increase of the OR LTPA participation levels is illustrated in Figure 2. The OR continuously decreased as the level of LTPA participation increased. In the next phase, the OR of diabetes was compared to the three different levels of cognitive function as the level of LTPA participation increased. The low cognitive function group was used as a baseline to compare the OR of diabetes with the mid and high LTPA groups. The equation consisted of three covariates (i.e., parameters): age, sex, and three different cognitive function levels. The OR of diabetes showed a negative slope with increasing age (OR = .99, Wald = 1.14, df = 1, P > .05) and sex (OR = .95, Wald = .40, df = 1, P > .05) but not at significant levels.

Figure 2.

Figure 2.

Cox proportional Hazard regression: Diabetes.

Among the three cognitive function groups (Table 4), the high group (OR = .43, Wald = 75.91, df = 1, P < .05) and the mid group (OR = .71, Wald = 16.30, df = 1, P < .05) had a larger negative slope coefficient than the low group even if these groups had the same cognitive function (Figure 3). In conclusion, the OR of diabetes decreased with increasing LTPA participation levels, and the high cognitive function group was found to have a larger negative OR coefficient than the mid and low cognitive function groups even if they reported the same level of LTPA participation.

Table 4.

Variables in the Equation.

B SE Wald df Sig Exp(B)
Age −.01 .00 1.14 1 .28 .99
Sex −.05 .07 .40 1 .52 .95
Low cognition group 75.96 2 .00*
Mid cognition group −.34 .08 16.30 1 .00* .71
High cognition group −.85 .09 75.91 1 .00* .43

*P < .05.

Figure 3.

Figure 3.

Dose-response curve in different cognitive function groups.

Discussion

This study demonstrates a longitudinal dose-response relationship between LTPA participation and the risk of diabetes, and a comparison of the risk of diabetes across different cognitive function groups. This study provides empirical evidence that LTPA participation reduces the risk of diabetes and gives evidence for the importance of cognitive function in reducing the prevalence of diabetes among older adults. This finding suggests that high levels of LTPA participation and cognitive function play an important role in reducing the risk of diabetes among older adults.

Substantial evidence has been presented in the literature that LTPA participation has been associated with reducing the risk of diabetes among older adults and increasing the health and wellbeing of people diagnosed with diabetes.33,34,40 Previous studies that were conducted using a cross-sectional methodology or in clinical settings reported that LTPA participation is effective in reducing the onset of diabetes among older adults.35,37–39 Our longitudinal study also indicates that 10 years of LTPA participation was a significant factor in the reduction of the prevalence of diabetes. This longitudinal study extends and supports previous findings.37–40 that LTPA participation is associated with a reduction in the risk of diabetes and the biomarkers related to diabetes. Our findings provide a cause-effect relationship between LTPA participation and the prevalence of diabetes, and it suggests that health professionals must continue to design and implement LTPA programs for older adults to reduce the onset of diabetes in this population.

As diabetes is recognized as a substantial risk factor for AD/ADRD, individuals diagnosed with diabetes face a 39% increased risk of AD and a 47% increased risk of dementia compared to nondiabetic patients.24,25 These studies demonstrate the negative effect of diabetes on cognitive function and indicate that older adults with diabetes are likely to experience cognitive decline and an increased risk of AD/ADRD. Prior studies have provided evidence that diabetes is negatively associated with cognitive function among older adults.16–19 Conversely, this study investigated the relationship between cognitive function and the onset of diabetes and found that the high cognitive function group exhibited a lower OR of diabetes compared to the mid and low cognitive function groups even though they had the same level of LTPA participation. This finding indicates that older adults who possess high levels of cognitive functioning are less likely to contract diabetes as it adds evidence to the literature that improving cognitive function among older adults can reduce the risk of diabetes in older adults that has heretofore been missing.

Overall, this study highlights the importance of LTPA participation as a strategy that can be used to reduce the risk of diabetes among older adults, and that improving cognitive function is essential to reducing the risk of diabetes for older adults. Based on these results, our study makes some practical suggestions on how to reduce the prevalence of diabetes among older adults. A recent systematic review and meta-analysis indicated that short-term (<1 year) multidomain (including two or more nonpharmacological components such as cognitive exercises and LTPA) intervention participation is associated with improvements in cognitive function in older adults when compared with single-domain interventions. 51 This study suggests that the design and implementation of a multidomain program that includes exercise programs and cognitive training (especially in a digital format) should be used to reduce the risk of diabetes in the older adult population.

Limitations

There are several limitations inherent to this study that can affect its application to future research. Considering the nature of the secondary data sets used, our research did not include the types of diabetes (e.g., type 1 or type 2) due to the lack of availability of this information. As different types of diabetes may affect the design and specific contents of an LTPA program, future studies are needed to investigate which type of diabetes are best addressed with LTPA and cognitive function training. Furthermore, this study did not consider the timing of participants' diabetes diagnoses between 2012 and 2020. As the time of diabetes diagnosis may affect the relationship between the prevalence of diabetes and LTPA, future researchers will be able to control the timeframe for how long the study samples have been diagnosed with diabetes. In addition, this study specified three cognitive function groups based on aggregate MoCA scores. Each category of cognitive function can be associated with LTPA participation and the onset of diabetes among older adults. Investigating the relationship between each cognitive category and LTPA participation provides more insightful information to researchers. Last, there are confounders that may affect the association between diabetes and LTPA participation such as comorbidities and other related factors (e.g., cardiovascular disease, heart function, and limitations to mobility and LTPA access). Future research is needed to investigate how these comorbidities and related factors are associated with the association between the onset of diabetes and LTPA participation.

Footnotes

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding: The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was carried out with the support of the ‘R&D Program for Forest Science Technology (Project No. 2021387D10-2323-0101),’ provided by the Korea Forest Service (Korea Forestry Promotion Institute).

Data Availability Statement

The datasets generated and analyzed during the current study are available at: https://hrs.isr.umich.edu/

Ethical Statement

Ethical Approval

The Institutional Review Board reviewed and approved the research protocols used to create and conduct the ongoing Health and Retirement Study. Additional IRB approval to conduct the secondary data analysis used in the present study was not required as this study did not involve the participation of human subjects. Additional approval from the IRB is not required to use HRS core data due to the fact that this study is not involved in human subject research (e.g., intervention research, interaction research), likewise previous studies using HRS data.

Informed Consent

This study used secondary data from the Health and Retirement Study (HRS). The consent form was gained when the data collection was originally conducted and an additional consent form was not required for this study.

ORCID iDs

Jungjoo Lee https://orcid.org/0000-0002-2963-0917

Junhyoung Kim https://orcid.org/0000-0001-5366-0270

References

  • 1.International Diabetes Federation . IDF Diabetes Atlas. 10th ed.; 2020. Available from www.diabetesatlas.org [Google Scholar]
  • 2.World Health Organization . Global report on diabetes. Published April 21, 2016. Available from: https://www.who.int/publications/i/item/9789241565257 [Google Scholar]
  • 3.American Diabetes Association . Statistics about Diabetes. Published July 28, 2022. Available from: https://diabetes.org/about-us/statistics/about-diabetes [Google Scholar]
  • 4.American Diabetes Association . Economic costs of diabetes in the U.S. in 2017. Diabetes Care. 2018;41(5):917-928 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.American Diabetes Association . Insulin affordability survey. Vault Consulting, LLC. Published May 22, 2018. http://main.diabetes.org/dorg/PDFs/2018-insulin-affordability-survey.pdf [Google Scholar]
  • 6.Saeedi P, Salpea P, Karuranga S. et al. Mortality attributable to diabetes in 20-79 years old adults, 2019 estimates: results from the International diabetes Federation diabetes Atlas, 9th edition. Diabetes Res Clin Pract. 2020;162:108086. [DOI] [PubMed] [Google Scholar]
  • 7.World Health Organization . Use of Glycated Hemoglobin (HbA1c) in the Diagnosis of Diabetes Mellitus: Abbreviated Report of a WHO Consultation; 2011. Available from https://apps.who.int/iris/handle/10665/70523 [PubMed] [Google Scholar]
  • 8.Campbell PT, Newton CC, Patel AV, Jacobs EJ, Gapstur SM. Diabetes and cause-specific mortality in a prospective cohort of one million US adults. Diabetes Care. 2012;35(9):1835-1844 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Gregg EW, Li Y, Wang J. et al. Changes in diabetes-related complications in the United States, 1990–2010. N Engl J Med. 2014;370(16):1514-1523 [DOI] [PubMed] [Google Scholar]
  • 10.Gordon-Dseagu VL, Shelton N, Mindell J. Diabetes mellitus and mortality from all-causes, cancer, cardiovascular and respiratory disease: evidence from the health survey for England and Scottish health survey cohorts. J Diabetes Complications. 2014;28(6):791-797 [DOI] [PubMed] [Google Scholar]
  • 11.Rao Kondapally Seshasai S, Kaptoge S, Thompson A. et al. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med. 2011;364(9):829-841 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Aune D, Norat T, Leitzmann M, Tonstad S, Vatten LJ. Physical activity and the risk of type 2 diabetes: a systematic review and dose–response meta-analysis. Eur J Epidemiol. 2015;30:529-542 [DOI] [PubMed] [Google Scholar]
  • 13.Boniol M, Dragomir M, Autier P, Boyle P. Physical activity and change in fasting glucose and HbA1c: a quantitative meta-analysis of randomized trials. Acta Diabetol. 2017;54:983-991 [DOI] [PubMed] [Google Scholar]
  • 14.Fang JY, Lin CH, Huang TH, Chuang SY. Correction: Fang et al. In Vivo rodent models of type 2 diabetes and their usefulness for evaluating flavonoid bioactivity. Nutrients. 2023;15(13):2881. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Gregg EW, Cheng YJ, Srinivasan M. et al. Trends in cause-specific mortality among adults with and without diagnosed diabetes in the USA: an epidemiological analysis of linked national survey and vital statistics data. Lancet. 2018;391(10138):2430-2440 [DOI] [PubMed] [Google Scholar]
  • 16.Antal B, McMahon LP, Sultan SF. et al. Type 2 diabetes mellitus accelerates brain aging and cognitive decline: Complementary findings from UK Biobank and meta-analyses. Elife. 2022;11:e73138. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Willmann C, Brockmann K, Wagner R. et al. Insulin sensitivity predicts cognitive decline in individuals with prediabetes. BMJ Open Diabetes Res Care. 2020;8(2):e001741. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Zhao Z, Li X, Jian D, Hao P, Rao L, Li M. Hsa_circ_0054633 in peripheral blood can be used as a diagnostic biomarker of pre-diabetes and type 2 diabetes mellitus. Acta Diabetol. 2017;54:237-245 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018;14(2):88-98 [DOI] [PubMed] [Google Scholar]
  • 20.Palta P, Carlson MC, Crum RM. et al. Diabetes and cognitive decline in older adults: the ginkgo evaluation of memory study. J Gerontol A Biol Sci Med Sci. 2017;73(1):123-130 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Matsuzaki T, Sasaki K, Tanizaki Y. et al. Insulin resistance is associated with the pathology of Alzheimer disease: the Hisayama study. Neurol. 2010;75(9):764-770] [DOI] [PubMed] [Google Scholar]
  • 22.Klunk WE. Amyloid imaging as a biomarker for cerebral β-amyloidosis and risk prediction for Alzheimer dementia. Neurobiol Aging. 2011;32 Suppl 1:S20-S36 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 2010;9(7):689-701 [DOI] [PubMed] [Google Scholar]
  • 24.Lu FP, Lin KP, Kuo HK. Diabetes and the risk of multi-system aging phenotypes: a systematic review and meta-analysis. PLoS One. 2009;4(1):e4144. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Willette AA, Bendlin BB, Starks EJ. et al. Association of insulin resistance with cerebral glucose uptake in late middle–aged adults at risk for Alzheimer disease. JAMA Neurol. 2015;72(9):1013-1020 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Moran A, Bundy B, Becker DJ, DiMeglio LA, Gitelman SE, Goland R, Greenbaum CJ, Herold KC, Marks JB, Raskin P, Sanda S, Schatz D, Wherrett DK, Wilson DM, Krischer JP, Skyler JS, Type 1 Diabetes TrialNet Canakinumab Study Group. Pickersgill L, de Koning E, Ziegler AG, Böehm B, Badenhoop K, Schloot N, Bak JF, Pozzilli P, Mauricio D, Donath MY, Castaño L, Wägner A, Lervang HH, Perrild H, Mandrup-Poulsen T, AIDA Study Group . Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials. Lancet. 2013;381(9881):1905-1915 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Koekkoek PS, Kappelle LJ, van den Berg E, Rutten GE, Biessels GJ. Cognitive function in patients with diabetes mellitus: guidance for daily care. Lancet Neurol. 2015;14(3):329-340 [DOI] [PubMed] [Google Scholar]
  • 28.Bullard T, Ji M, An R, Trinh L, Mackenzie M, Mullen SP. A systematic review and meta-analysis of adherence to physical activity interventions among three chronic conditions: cancer, cardiovascular disease, and diabetes. BMC Publ Health. 2019;19(1):636-711 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Zhao L, Zhang F, Ding X. et al. Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes. Science. 2018;359(6380):1151-1156 [DOI] [PubMed] [Google Scholar]
  • 30.Chudyk A, Petrella RJ. Effects of exercise on cardiovascular risk factors in type 2 diabetes: a meta-analysis. Diabetes Care. 2011;34(5):1228-1237 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Colberg SR, Sigal RJ, Yardley JE. et al. Physical activity/exercise and diabetes: a position statement of the American Diabetes Association. Diabetes Care. 2016;39(11):2065-2079 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Wing RR, Goldstein MG, Acton KJ. et al. Behavioral science research in diabetes: lifestyle changes related to obesity, eating behavior, and physical activity. Diabetes Care. 2001;24(1):117-123 [DOI] [PubMed] [Google Scholar]
  • 33.Umpierre D, Ribeiro PAB, Schaan BD, Ribeiro JP. Volume of supervised exercise training impacts glycaemic control in patients with type 2 diabetes: a systematic review with meta-regression analysis. Diabetologia. 2013;56:242-251 [DOI] [PubMed] [Google Scholar]
  • 34.Liubaoerjijin Y, Terada T, Fletcher K, Boulé NG. Effect of aerobic exercise intensity on glycemic control in type 2 diabetes: a meta-analysis of head-to-head randomized trials. Acta Diabetol. 2016;53:769-781 [DOI] [PubMed] [Google Scholar]
  • 35.Sluik D, Buijsse B, Muckelbauer R. et al. Physical activity and mortality in individuals with diabetes mellitus: a prospective study and meta-analysis. Arch Intern Med. 2012;172(17):1285-1295 [DOI] [PubMed] [Google Scholar]
  • 36.Anderson AE, Kerr WT, Thames A, Li T, Xiao J, Cohen MS. Electronic health record phenotyping improves detection and screening of type 2 diabetes in the general United States population: a cross-sectional, unselected, retrospective study. J Biomed Inform. 2016;60:162-168 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Gregg EW, Gerzoff RB, Caspersen CJ, Williamson DF, Narayan KMV. Relationship of walking to mortality among US adults with diabetes. Arch Intern Med. 2003;163(12):1440-1447 [DOI] [PubMed] [Google Scholar]
  • 38.Hu FB, Van Dam RM, Liu S. Diet and risk of type II diabetes: the role of types of fat and carbohydrate. Diabetologia. 2001;44:805-817 [DOI] [PubMed] [Google Scholar]
  • 39.Hu FB, Stampfer MJ, Solomon CG. et al. The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20 years of follow-up. Arch Intern Med. 2001;161(14):1717-1723 [DOI] [PubMed] [Google Scholar]
  • 40.Diabetes Canada Clinical Practice Guidelines Expert Committee. Sigal RJ, Armstrong MJ, Bacon SL. et al. Physical activity and diabetes. Can J Diabetes. 2018;42:S54-S63 [DOI] [PubMed] [Google Scholar]
  • 41.Lee S, Lee C, An J. Psycho-social correlates of leisure-time physical activity (LTPA) among older adults: a multivariate analysis. Eur Rev Aging Phys Act. 2020;17(1):6-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Lee J, Oh SM, Kim J, Kim J. Different levels of leisure walking and Mental health among older adults with mild cognitive impairment. J Aging Phys Act. 2023;31:841-848 [DOI] [PubMed] [Google Scholar]
  • 43.Ciesielska N, Sokołowski R, Mazur E, Podhorecka M, Polak-Szabela A, Kędziora-Kornatowska K. Is the montreal cognitive assessment (MoCA) test better suited than the mini-mental state examination (MMSE) in mild cognitive impairment (MCI) detection among people aged over 60? Meta-analysis. Psychiatr Pol. 2016;50(5):1039-1052 [DOI] [PubMed] [Google Scholar]
  • 44.Fisher GG, Hassan H, Rodgers WL, Weir DR. Health and Retirement Study Imputation of Cognitive Functioning Measures: 1992-2010. Ann Arbor: Institute for Social Research, Survey Research Center, University of Michigan; 2013. [Google Scholar]
  • 45.Ofstedal MB, Fisher GG, Herzog AR. Documentation of Cognitive Functioning Measures in the Health and Retirement Study. Ann Arbor: University of Michigan; 2005. [Google Scholar]
  • 46.Strawbridge WJ, Wallhagen MI. Self-rated health and mortality over three decades. Res Aging. 1999;21(3):402-416 [Google Scholar]
  • 47.Vagelatos NT, Eslick GD. Type 2 diabetes as a risk factor for Alzheimer's disease: the confounders, interactions, and neuropathology associated with this relationship. Epidemiol Rev. 2013;35(1):152-160 [DOI] [PubMed] [Google Scholar]
  • 48.van Manen JG, van Dijk PC, Stel VS. et al. Confounding effect of comorbidity in survival studies in patients on renal replacement therapy. Nephrol Dial Transplant. 2007;22(1):187-195 [DOI] [PubMed] [Google Scholar]
  • 49.Zhang T, Mei Q, Zhang Z. et al. Risk for newly diagnosed diabetes after COVID-19: a systematic review and meta-analysis. BMC Med. 2022;20(1):444-510 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Doornik JA, Hansen H. An omnibus test for univariate and multivariate normality. Oxf Bull Econ Stat. 2008;70:927-939 [Google Scholar]
  • 51.Hafdi M, Eggink E, Hoevenaar-Blom MP. et al. Design and development of a mobile health (mHealth) platform for dementia prevention in the prevention of dementia by mobile phone applications (PRODEMOS) project. Front Neurol. 2021;12:733878. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The datasets generated and analyzed during the current study are available at: https://hrs.isr.umich.edu/


Articles from American Journal of Alzheimer's Disease and Other Dementias are provided here courtesy of SAGE Publications

RESOURCES